Skip to content

The Effect of l Dexamethasone on Post Cesarean Section Pain

A Clinical Trial to Assess the Effect of Combination of Interathecal Dexamethasone with Lidocaine and Narcotics on Post Cesarean Section Pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015060819470N22
Enrollment
60
Registered
2015-08-06
Start date
2009-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean. Maternal care for multiple gestation with malpresentation of one fetus or more

Interventions

Intervention 1: 70 mg lidocaine intrathecally for spinal anesthesia. Intervention 2: 70 mg lidocaine combined with 0.15 mg morphine for spinal anesthesia. Intervention 3: 70 mg lidocaine with 4 mg de
Treatment - Drugs
70 mg lidocaine intrathecally for spinal anesthesia
70 mg lidocaine combined with 0.15 mg morphine for spinal anesthesia
70 mg lidocaine with 4 mg dexamethasone for spinal anesthesia

Sponsors

Vice Chancellor for Research, Shiraz University of Medical S
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: women with a gestational age of 38-42 weeks; ASA I and II; literate. Exclusions criteria: pregnant woman who had received any analgesics during the prior 48 hours; addiction to the drugs ; hypersensitivity to the administered drugs (lidocaine, dexamethasone, morphine); positive history of mental illness.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative pain. Timepoint: At 4 ,8,12,24 hours after surgery. Method of measurement: NRS(Numerical Rating Scale).

Secondary

MeasureTime frame
Apgar. Timepoint: At the first and fifth min after birth. Method of measurement: Apgar Scoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Maghsodi

Shiraz University of Medical Sciences

maghsodb@yahoo.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026